Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers [Phase 1]

View source ↗

Summary

Phase 1 exploratory study evaluating FAPi PET/CT imaging with histopathology validation in patients with various cancers. The trial collects imaging data across…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FAPi PET/CT tracer (Fibroblast Activation Protein inhibitor imaging tracer)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Bladder Carcinoma, Cervical Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING